Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
How ex-construction worker Sean Richardson MPS is building his pharmacy career
When an injury cut short his career in construction, Sean Richardson MPS threw himself into pharmacy study and discovered a newfound passion for healthcare.
Countdown to the biggest pharmacy event of the year
With a new host and massive new venue, this year’s conference promises to be the biggest and best one yet.
Pharmacy Student of the Year announced for 2018
University of Canberra’s Ben Coghlan has won the 2018 PSA Pharmacy Student of the Year (PSOTY) Award, announced at the PSA18 gala dinner last...
Travel health: ready for take-off
Turning informal advice into a structured consultation service: pharmacy-based travel health services take flight.
New global goals for pharmacy
Promoting antimicrobial stewardship, patient safety and digital health are just three of the new global goals for pharmacy launched by FIP on Monday.
Long COVID: managing the after-effects
Some people who are infected with COVID-19 do not recover quickly. They live with the aftermath – long COVID – a multi-system condition that we must start learning how to manage, including pharmacists.
